Skip to main content

Schrodinger, Inc.

SDGR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001490978

In the last 90 days, Schrodinger, Inc. insiders filed 0 open-market purchases and 2 sales; 231 institutions reported holding it in 13F filings for Q2 2026, worth $1.05B in total; superinvestors Gates Foundation Trust and ARK Invest hold it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Schrodinger, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
2 filings
2 insiders, $941.6K in total
Insiders trading
2
Net value
−$941.6K
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Schrodinger, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Schrodinger, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Akinsanya KarenSee Remarks69,956Sep 21, 20263
Jain RachitEVP & CFO50,877Jul 17, 20264
Friesner RichardDirector679,373IndirectJun 29, 20263
Ginsberg Gary LDirector25,388Jun 23, 20261
Oberoi ArunDirector25,388Jun 23, 20261
van Kralingen Bridget ADirector19,640Jun 23, 20261
Lynton MichaelDirector25,388Jun 23, 20261
Chodakewitz JeffreyDirector25,388Jun 23, 20261
Sender GaryDirector25,388Jun 23, 20261
Thornberry NancyDirector25,388Jun 23, 20261
Kapeller-Libermann RosanaDirector25,388Jun 23, 20261
Farid RamyPresident & CEO405,351Apr 17, 20263
Lorton Kenneth PatrickEVP, CTO & COO, Software89,241Mar 6, 20263
Tran YvonneEVP, CLO & CPO52,683Mar 6, 20263
Herman JennyCAO34,804Mar 6, 20263
Abel Robert LorneSee Remarks55,897Mar 6, 20263
Aklian Mannix VartanSee Remarks31,193Mar 3, 20261
Dugan MargaretChief Medical Officer24,574Oct 17, 20251
Porges Geoffrey CraigEVP & CFO27,544Mar 4, 20250
Lebowitz JoelEVP & CFO0Sep 3, 20210
Shaw David E10% Owner6,103,042IndirectJul 19, 20210
Schrodinger Equity Holdings, LLC10% Owner6,103,042IndirectJul 19, 20210

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 21, 2026 (view filing)5:15 PM ETSep 174 daysAkinsanya KarenSee RemarksSSale−31.6K$29.37−$928.0K−31.1%70.0K after2 lots10b5-1
Jul 17, 2026 (view filing)5:09 PM ETJul 161 dayJain RachitEVP & CFOSSale−875$15.60−$13.6K−1.7%50.9K after10b5-1
Apr 17, 2026 (view filing)Apr 161 dayJain RachitEVP & CFOSSale−844$12.75−$10.8K−1.6%51.8K after10b5-1
Apr 17, 2026 (view filing)Apr 16-171 dayFarid RamyPresident & CEOSSale−86.0K$12.27−$1.06M−20.6%330.8K after2 lots10b5-1
Mar 6, 2026 (view filing)Mar 51 dayJain RachitEVP & CFOSSale−1.63K$12.90−$21.0K−3.0%52.6K after10b5-1
Mar 6, 2026 (view filing)Mar 42 daysAbel Robert LorneSee RemarksSSale−1.30K$12.81−$16.7K−2.3%55.9K after10b5-1
Mar 6, 2026 (view filing)Mar 5-61 dayHerman JennyCAOSSale−1.38K$12.85−$17.8K−3.8%34.8K after2 lots10b5-1
Mar 6, 2026 (view filing)Mar 51 dayTran YvonneEVP, CLO & CPOSSale−1.09K$12.90−$14.1K−2.0%52.7K after10b5-1
Mar 6, 2026 (view filing)Mar 51 dayLorton Kenneth PatrickEVP, CTO & COO, SoftwareSSale−1.22K$12.90−$15.8K−1.4%89.2K after10b5-1
Mar 6, 2026 (view filing)Mar 51 dayFarid RamyPresident & CEOSSale−3.66K$12.91−$47.3K−1.1%330.8K after10b5-1
Mar 6, 2026 (view filing)Mar 51 dayAkinsanya KarenSee RemarksSSale−1.37K$12.90−$17.6K−1.9%70.0K after10b5-1
Mar 3, 2026 (view filing)Mar 21 dayFarid RamyPresident & CEOSSale−5.56K$11.90−$66.2K−1.6%334.5K after10b5-1
Mar 3, 2026 (view filing)Mar 21 dayAkinsanya KarenSee RemarksSSale−2.21K$11.99−$26.4K−3.0%71.3K after10b5-1
Feb 12, 2026 (view filing)Feb 102 daysHerman JennyCAOSSale−752$13.79−$10.4K−2.7%26.6K after10b5-1
Feb 12, 2026 (view filing)Feb 102 daysTran YvonneEVP, CLO & CPOSSale−776$13.80−$10.7K−3.3%22.9K after10b5-1
Feb 12, 2026 (view filing)Feb 102 daysLorton Kenneth PatrickEVP, CTO & COO, SoftwareSSale−925$13.73−$12.7K−1.7%52.7K after10b5-1
Feb 11, 2026 (view filing)Feb 92 daysAbel Robert LorneSee RemarksSSale−1.23K$13.51−$16.6K−6.0%19.4K after10b5-1
Oct 17, 2025 (view filing)Oct 161 dayDugan MargaretChief Medical OfficerSSale−1.40K$21.07−$29.4K−5.4%24.6K after10b5-1
Apr 15, 2025 (view filing)Apr 141 dayAkinsanya KarenPresident of R&D, TherapeuticsSSale−16.7K$25.09−$419.5K−51.7%15.6K after3 lots10b5-1
Mar 7, 2025 (view filing)Mar 61 dayHerman JennySVP & ControllerSSale−666$21.11−$14.1K−2.4%27.3K after10b5-1
Mar 4, 2025 (view filing)Mar 31 dayPorges Geoffrey CraigEVP & CFOSSale−5.49K$21.76−$119.5K−16.6%27.5K after
Feb 19, 2025 (view filing)Feb 181 dayTran YvonneEVP, CLO & CPOSSale−3.90K$28.00−$109.3K−25.9%11.1K after10b5-1
Feb 12, 2025 (view filing)Feb 102 daysAbel Robert LorneSee RemarksSSale−1.23K$25.99−$31.8K−13.1%8.12K after10b5-1
Feb 12, 2025 (view filing)Feb 111 dayLorton Kenneth PatrickEVP, CTO & COO, SoftwareSSale−985$24.43−$24.1K−2.3%41.1K after10b5-1
Feb 12, 2025 (view filing)Feb 111 dayHerman JennySVP & ControllerSSale−859$24.43−$21.0K−4.5%18.2K after10b5-1
Feb 12, 2025 (view filing)Feb 111 dayTran YvonneEVP, CLO & CPOSSale−828$24.43−$20.2K−6.9%11.1K after10b5-1
Oct 16, 2024 (view filing)Oct 151 dayDugan MargaretChief Medical OfficerSSale−1.53K$17.78−$27.2K−10.2%13.5K after10b5-1
Mar 5, 2024 (view filing)Mar 41 dayPorges Geoffrey CraigEVP & CFOSSale−3.31K$26.35−$87.4K−36.8%5.68K after
Feb 13, 2024 (view filing)Feb 121 dayTran YvonneEVP, CLO & CPOSSale−758$28.29−$21.4K−6.0%12.0K after10b5-1
Feb 13, 2024 (view filing)Feb 121 dayAbel Robert LorneSee RemarksSSale−1.21K$27.55−$33.2K−11.4%9.34K after10b5-1
Feb 13, 2024 (view filing)Feb 121 dayHerman JennySVP & ControllerSSale−787$28.29−$22.3K−6.3%11.8K after10b5-1
Feb 13, 2024 (view filing)Feb 121 dayLorton Kenneth PatrickEVP, CTO & COO, SoftwareSSale−901$28.29−$25.5K−2.4%36.5K after10b5-1
Aug 10, 2023 (view filing)Aug 91 dayLorton Kenneth PatrickEVP & Chief Technology OfficerSSale−10.0K$40.06−$400.6K−21.1%37.4K after10b5-1
Jul 3, 2023 (view filing)Jun 303 daysTran YvonneEVP, CLO & CPOSSale−12.0K$50.00−$602.0K−48.6%12.7K after
May 24, 2023 (view filing)May 22-232 daysTran YvonneEVP, CLO & CPOSSale−23.0K$36.76−$844.1K−64.3%12.7K after2 lots
May 24, 2023 (view filing)May 231 dayLorton Kenneth PatrickEVP & Chief Technology OfficerSSale−10.0K$40.06−$400.6K−17.4%47.4K after
May 23, 2023 (view filing)May 221 dayThornberry NancyDirectorSSale−14.8K$35.00−$519.8K−100.0%0 after
Feb 3, 2023 (view filing)Feb 21 dayTran YvonneEVP & Chief Legal OfficerSSale−25.0K$27.26−$681.5K−83.0%5.13K after
Jan 5, 2023 (view filing)Jan 41 dayFarid RamyPresident & CEOSSale−66.9K$18.28−$1.22M−26.6%184.4K after
Aug 12, 2022 (view filing)Aug 111 dayThornberry NancyDirectorSSale−4.95K$35.00−$173.3K−100.0%0 after
Dec 14, 2021 (view filing)Dec 131 dayAbel Robert LorneSee RemarksSSale−15.6K$36.28−$566.0K−100.0%0 after2 lots
Oct 19, 2021 (view filing)Oct 154 daysAkinsanya KarenSee RemarksSSale−1.39K$55.75−$77.7K−100.0%0 after
Sep 16, 2021 (view filing)Sep 151 dayAkinsanya KarenSee RemarksSSale−1.39K$61.13−$85.2K−100.0%0 after
Sep 14, 2021 (view filing)Sep 131 dayAbel Robert LorneSee RemarksSSale−15.6K$61.75−$963.4K−100.0%0 after2 lots
Sep 3, 2021 (view filing)Sep 1-22 daysLebowitz JoelEVP & CFOSSale−5.57K$64.59−$360.0K−100.0%0 after2 lots
Aug 17, 2021 (view filing)Aug 161 dayAkinsanya KarenSee RemarksSSale−37.7K$57.74−$2.18M−100.0%0 after2 lots
Aug 4, 2021 (view filing)Aug 22 daysTran YvonneEVP & Chief Legal OfficerSSale−12.0K$68.17−$818.0K−70.0%5.13K after3 lots
Jul 19, 2021 (view filing)6:45 PM ETJul 19Same dayShaw David E and 1 other10% OwnerSSaleCommon Stock, par value $0.01 per share−63.1K$68.07−$4.29M−1.0%6.10M after4 lots
Jul 16, 2021 (view filing)5:55 PM ETJul 15-161 dayShaw David E and 1 other10% OwnerSSaleCommon Stock, par value $0.01 per share−88.4K$66.78−$5.90M−1.4%6.17M after6 lots
Jul 16, 2021 (view filing)Jul 142 daysLebowitz JoelEVP & CFOSSale−5.57K$68.04−$379.3K−100.0%0 after3 lots